Anticancer Potential and Other Pharmacological Properties of Prunus armeniaca L.: An Updated Overview

Abstract

Prunus armeniaca L. (Rosaceae)-syn. Amygdalus armeniaca (L.) Dumort., Armeniaca armeniaca (L.) Huth, Armeniaca vulgaris Lam is commonly known as the apricot tree. The plant is thought to originate from the northern, north-western, and north-eastern provinces of China, although some data show that it may also come from Korea or Japan. The apricot fruit is used medicinally to treat a variety of ailments, including use as an antipyretic, antiseptic, anti-inflammatory, emetic, and ophthalmic remedy. The Chinese and Korean pharmacopeias describe the apricot seed as an herbal medicinal product. Various parts of the apricot plant are used worldwide for their anticancer properties, either as a primary remedy in traditional medicine or as a complementary or alternative medicine. The purpose of this review was to provide comprehensive and up-to-date information on ethnobotanical data, bioactive phytochemicals, anticancer potential, pharmacological applications, and toxicology of the genus Prunus armeniaca, thus providing new perspectives on future research directions. Included data were obtained from online databases such as PubMed/Medline, Google Scholar, Science direct, and Wiley Online Library. Multiple anticancer mechanisms have been identified in in vitro and in vivo studies, the most important mechanisms being apoptosis, antiproliferation, and cytotoxicity. The anticancer properties are probably mediated by the contained bioactive compounds, which can activate various anticancer mechanisms and signaling pathways such as tumor suppressor proteins that reduce the proliferation of tumor cells. Other pharmacological properties resulting from the analysis of experimental studies include neuroprotective, cardioprotective, antioxidant, immunostimulatory, antihyperlipidemic, antibacterial, and antifungal effects. In addition, data were provided on the toxicity of amygdalin, a compound found in apricot kernel seeds, which limits the long-term use of complementary/alternative products derived from P. armeniaca. This updated review showed that bioactive compounds derived from P. armeniaca are promising compounds for future research due to their important pharmacological properties, especially anticancer. A detailed analysis of the chemical structure of these compounds and their cytotoxicity should be carried out in future research. In addition, translational pharmacological studies are required for the correct determination of pharmacologically active doses in humans.

Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles

“…Because artemisinin interactions with other drugs are not fully known, future clinical studies are needed to establish their potential interaction mechanisms. Other limitations derive from the amounts of active ingredients in plants, depending on the area of cultivation and climate [228][229][230]. Also, the absorption of bioactive compounds rapidly and in variable quantities requires the future development of pharmaceutical nanoformulations that will improve the bioavailability and implicitly an increased therapeutic efficacy [231,232].…”

Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation

“…Limitations of tumor biomarker-based detection in clinical cases derive from not discovering all the mutations and pathways involved in oncogenesis; as well as the mechanisms that allow the tumor to evade the immune system response, as data show that activation of oncogenesis pathways leads to immune system impairment [3,72,73]. Significant effort will be needed in the coming years to define and validate biomarkers that allow patient selection for personalized cancer management [74][75][76][77].…”

Recent updates on anticancer mechanisms of polyphenols

“…Transformed cells acquire new properties that can have a significant impact on local structures or the whole organism. Cells that proliferate acquire new properties (e.g., gain independence from the systems that control the progression of the cell cycle, and develop the ability to invade other tissues) that can alter the body’s homeostasis and predispose to pathological conditions that can have an unfortunate prognosis ( Sharifi-Rad et al, 2021a ; Jain et al, 2021 ; Kitic et al, 2022 ).…”

“…Considering this, metastasis is one of the primary causes of cancer-related mortality ( Javed et al, 2022 ). However, a big part of cancer-related fatalities can be mitigated or averted by avoiding risk factors and following evidence-based preventative interventions ( Hossain et al, 2022 ; Kitic et al, 2022 ). Several medications and therapies such as chemotherapy and radiation have been used to treat cancer ( Rizvi et al, 2021b ; Quetglas-Llabrés et al, 2022 ).…”